ArticleCancer science2010

Inhibition of ErbB2 by Herceptin reduces survivin expression via the ErbB2-beta-catenin/TCF4-survivin pathway in ErbB2-overexpressed breast cancer cells.

Hongxia Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.